Cargando…

Clinical Characteristics of Molecularly Defined Renal Cell Carcinomas

Kidney tumors comprise a broad spectrum of different histopathological entities, with more than 0.4 million newly diagnosed cases each year, mostly in middle-aged and older men. Based on the description of the 2022 World Health Organization (WHO) classification of renal cell carcinoma (RCC), some ne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Xinfeng, Tan, Congzhu, Zhu, Guodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297654/ https://www.ncbi.nlm.nih.gov/pubmed/37367052 http://dx.doi.org/10.3390/cimb45060303

Ejemplares similares

Clinical Characteristics and Current Status of Treatment for Recurrent Bladder Cancer after Surgeries on Upper Tract Urothelial Carcinoma
por: Hu, Xinfeng, et al.
Publicado: (2023)

Investigating the Role of FoxP3 in Renal Cell Carcinoma Metastasis with BAP1 or SEDT2 Mutation
por: Xu, Shan, et al.
Publicado: (2023)

Hepatocellular carcinoma: Understanding molecular mechanisms for defining potential clinical modalities
por: Natu, Abhiram, et al.
Publicado: (2021)

The Molecular Characteristics of Non-Clear Cell Renal Cell Carcinoma: What’s the Story Morning Glory?
por: Marchetti, Andrea, et al.
Publicado: (2021)

Comprehensive Analysis of Senescence Characteristics Defines a Novel Prognostic Signature to Guide Personalized Treatment for Clear Cell Renal Cell Carcinoma
por: Zhou, Peng, et al.
Publicado: (2022)

Molecular Classification of Renal Cell Carcinoma and Its Implication in Future Clinical Practice
por: Casuscelli, Jozefina, et al.
Publicado: (2017)

The Clinical and Molecular Features in the VHL Renal Cancers; Close or Distant Relatives with Sporadic Clear Cell Renal Cell Carcinoma?
por: Cinque, Alessandra, et al.
Publicado: (2022)

Characteristics and Treatment Challenges of Non-Clear Cell Renal Cell Carcinoma
por: Sepe, Pierangela, et al.
Publicado: (2021)

Characteristics of Clear Cell Papillary Renal Cell Carcinoma (ccpRCC)
por: Rysz, Jacek, et al.
Publicado: (2021)

Defining Tumour Shape Irregularity for Preoperative Risk Stratification of Clinically Localised Renal Cell Carcinoma
por: Tanaka, Hajime, et al.
Publicado: (2022)

Glycosylation in Renal Cell Carcinoma: Mechanisms and Clinical Implications
por: Zhu, Xinqing, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Sarcomatoid Dedifferentiation in Renal Cell Carcinoma: From Novel Molecular Insights to New Clinical Opportunities
por: Debien, Véronique, et al.
Publicado: (2019)

MiTF/TFE Translocation Renal Cell Carcinomas: From Clinical Entities to Molecular Insights
por: Simonaggio, Audrey, et al.
Publicado: (2022)

Phytochemicals for the Prevention and Treatment of Renal Cell Carcinoma: Preclinical and Clinical Evidence and Molecular Mechanisms
por: Bajalia, Essa M., et al.
Publicado: (2022)

Characteristics and Outcome of Children with Renal Cell Carcinoma: A Narrative Review
por: van der Beek, Justine N., et al.
Publicado: (2020)

Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Translocation Renal Cell Carcinoma: An Update on Clinicopathological and Molecular Features
por: Inamura, Kentaro
Publicado: (2017)

Emerging Molecular Technologies in Renal Cell Carcinoma: Liquid Biopsy
por: Cimadamore, Alessia, et al.
Publicado: (2019)

Genomic Profiling and Molecular Characterization of Clear Cell Renal Cell Carcinoma
por: Pezzicoli, Gaetano, et al.
Publicado: (2023)

T and NK cell abundance defines two distinct subgroups of renal cell carcinoma
por: Lee, Moon Hee, et al.
Publicado: (2022)

Clinical characteristics and outcomes in renal transplant recipients with renal cell carcinoma in the native kidney
por: Sun, In O, et al.
Publicado: (2013)

Comprehensive investigation into cuproptosis in the characterization of clinical features, molecular characteristics, and immune situations of clear cell renal cell carcinoma
por: Wang, Bao, et al.
Publicado: (2022)

Genetic and Epigenetic Characteristics in Isolated Pancreatic Metastases of Clear-Cell Renal Cell Carcinoma
por: Sellner, Franz, et al.
Publicado: (2023)

Familial renal cell carcinoma: clinical and molecular genetic aspects
por: Maher, E.R., et al.
Publicado: (1991)

Clinical Characteristics of Patients With Renal Cell Carcinoma and Metastasis to the Thyroid Gland
por: Jackson, Gregory, et al.
Publicado: (2017)

Clinical Characteristics and Prognosis of Renal Cell Carcinoma With Spinal Bone Metastases
por: Zhai, Jianpo, et al.
Publicado: (2021)

Cystic Clear Cell Renal Cell Carcinoma: A Morphological and Molecular Reappraisal
por: Pini, Giacomo Maria, et al.
Publicado: (2023)

Molecular and Metabolic Subtypes in Sporadic and Inherited Clear Cell Renal Cell Carcinoma
por: Czyzyk-Krzeska, Maria F., et al.
Publicado: (2021)

Chromophobe renal cell carcinoma: Novel molecular insights and clinicopathologic updates
por: Alaghehbandan, Reza, et al.
Publicado: (2022)

Molecular mechanism of circRNAs in drug resistance in renal cell carcinoma
por: Qin, Shuang, et al.
Publicado: (2022)

BAP1 loss defines a new class of renal cell carcinoma
por: Peña-Llopis, Samuel, et al.
Publicado: (2012)

Defining the origin, evolution, and immune composition of SDH-deficient renal cell carcinoma
por: Neves, Joana B., et al.
Publicado: (2022)

Clinicopathological and Molecular Characteristics of Macroscopically Yellowish-Colored Chromophobe Renal Cell Carcinoma Compared to Non-Yellowish-Colored Chromophobe Renal Cell Carcinoma
por: Kojima, Fumiyoshi, et al.
Publicado: (2021)

Metabolic classifications of renal cell carcinoma reveal intrinsic connections with clinical and immune characteristics
por: Li, Le, et al.
Publicado: (2023)

Progress of Molecular Targeted Therapies for Advanced Renal Cell Carcinoma
por: Conti, Alessandro, et al.
Publicado: (2013)

Circulating microRNAs from the Molecular Mechanisms to Clinical Biomarkers: A Focus on the Clear Cell Renal Cell Carcinoma
por: Tito, Claudia, et al.
Publicado: (2021)

Prognostic Immunophenotyping Clusters of Clear Cell Renal Cell Carcinoma Defined by the Unique Tumor Immune Microenvironment
por: Xu, Wenhao, et al.
Publicado: (2021)

Transcriptional Programs Define Molecular Characteristics of Innate Lymphoid Cell Classes and Subsets
por: Robinette, Michelle L., et al.
Publicado: (2015)

Metabolic syndrome and renal cell carcinoma
por: Zhang, Gui-Ming, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7atq0m87b1vmj7asr9cbffl7op